novo nordisk weight loss

FDA, Wegovy and Novo Nordisk

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.

NBC New York · 1d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Business Insider · 1d

Shortage of Novo Nordisk’s (NVO) Weight Loss Drugs Is Resolved, Says FDA

The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration

1don MSN

Why Novo Nordisk Stock Popped on Friday

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

18don MSN

Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA

Novo Nordisk stock rose Wednesday after the drugmaker reported quarterly earnings above analysts’ expectations, but forecast slower growth ahead.Novo posted fourth-quarter earnings of 6.34 ($0.88) ...

FiercePharma1d

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

These Drugs Could Offset the Side Effects of Weight Loss

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Weight-loss drugs are about to get a lot better

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

Are Weight Loss Injections Safe? What to Know Before Starting One

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Hosted on MSN6d

Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside

Shares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 ...

PA Media on MSN6d

Novo Nordisk reprimanded for allegedly failing to disclose payments

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results